Search
bacitracin (AK-tracin)
Ophthalmic: Tradename: AK-tracin
Indications:
1) treatment of superficial bacterial skin infections
2) treatment of eye infections
- conjunctivitis, keratitis, blepharitis, meibomitis, dacryocystitis, corneal ulcers
Dosage:
Topical:
Ointment: apply 1-5 times daily. Ointment. 30 g.
Ophthalmic:
- ointment every 3-4 hours or BID-QID for 7-10 days
- apply light pressure on conjunctival sac for 1 minute after instillation
- may cause blurred vision
Antimicrobial activity:
- Streptococcus
- Staphylococcus
- Anaerobic cocci
- Corynebacterium
- Clostridium
- Neisseria gonorrhoeae
- Neisseria meningitidis
- Fusobacterium
- Actinomyces israelii
- Treponema pallidum
- Treponema vincenti
Adverse effects:
1) topical
- rash, allergic contact dermatitis
- itching
2) ophthalmic
- blurred vision
- not common (1-10%)
- sweating, hypotension, rash, itching, anorexia, nausea/vomiting, diarrhea, blood dyscrasias, chest tightness, swelling of face & lips, rectal itching & burning, pain
Mechanism of action:
- inhibits bacterial cell wall synthesis
Interactions
drug interactions
Specific
Bacitracin Ophthalmic
General
other antibiotic
Properties
MISC-INFO: pregnancy-category C
safety in lactation ?
Database Correlations
PUBCHEM correlations
References
- The Pharmacological Basis of Therapeutics, 9th ed.
Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Drug Information & Medication Formulary, Veterans Affairs,
Central California Health Care System, 1st ed., Ravnan et al
eds, 1998
- Kaiser Permanente Northern California Regional Drug
Formulary, 1998
- Deprecated Reference
Component-of
bacitracin/colistin/cortisol
bacitracin/cortisol/neomycin/polymixin b
bacitracin/dimethicone/zinc oxide
bacitracin/lidocaine
bacitracin/lidocaine/neomycin
bacitracin/lidocaine/neomycin/polymixin b
bacitracin/neomycin
bacitracin/neomycin/polymixin b/pramoxine
bacitracin/neomycin/polymixin-B (Neosporin)
bacitracin/polymixin-B (Polysporin, Ocumycin)